Anemia Clinical Trial
— MCHOfficial title:
Effects of Video-based Health Education on Health Status of Pregnant Mothers and Their Infants (From 0 to 6 Months) in Dirashe District Southern Ethiopia - a Cluster Randomized Controlled Trial.
NCT number | NCT04414527 |
Other study ID # | BC-06756 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | March 13, 2020 |
Est. completion date | July 31, 2021 |
Verified date | December 2021 |
Source | University Ghent |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Low adherence to recommended health and nutrition strategies during the critical 1000 day-window of opportunity is multifactorial but low quality communication is key limitation. Innovative strategies to improve interpersonal communication can reduce the burden and the fatigue of community health workers and may result in a greater change. The findings of this project will support governments and other stakeholders in their delivery of high impact nutrition and health practices. This intervention aims to improve adherence to ante- and post-natal care practices and recommendations by the use of our video-based health education. These videos will be implemented through home-based counseling by trained assistants, and video-based forum participation led by community nurses and health extension workers (HEWs). During the monthly forums, the educational package will be delivered in a video form - locally prepared using multiple approaches like testimony, comedy, dramas in the form of questions and answers, group discussions and deductive approaches. Cordless projectors and locally created videos give the health community more quality control over the end message, expand the number of people reached, allow for the use of minimally trained non-expert facilitators such as the hews, and allow for contextually appropriate information. They can also be used in areas without access to electricity, helping to bridge the digital divide, and serving as a leapfrog technology for areas that would otherwise not have access to media.
Status | Completed |
Enrollment | 675 |
Est. completion date | July 31, 2021 |
Est. primary completion date | July 31, 2021 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Signed informed consent form - Aged at least 18 years - Permanent resident of the village of the study intervention/control - Planned availability during the whole period of the study (12 months) - Acceptance of the intervention package including home visits for data collection and morbidity follow up. Exclusion Criteria: - Severe anemia (hemoglobin <70 g/L), - Under nutrition (defined as body mass index before pregnancy of <18.5 kg/m2), - Chronically ill mothers with tuberculosis or other chronic diseases, - Reported HIV-positive mother. - Individuals with anatomical deformity will be excluded due to the difficulty of measurement of height. |
Country | Name | City | State |
---|---|---|---|
Ethiopia | Arba Minch University | Arba Minch | Dirashe District |
Lead Sponsor | Collaborator |
---|---|
University Ghent | College of Medicine and Health Sciences, Arba Minch University, Ethiopia, Flemish Interuniversity Council (VLIR) |
Ethiopia,
Ashorn P, Hallamaa L, Allen LH, Ashorn U, Chandrasiri U, Deitchler M, Doyle R, Harjunmaa U, Jorgensen JM, Kamiza S, Klein N, Maleta K, Nkhoma M, Oaks BM, Poelman B, Rogerson SJ, Stewart CP, Zeilani M, Dewey KG. Co-causation of reduced newborn size by maternal undernutrition, infections, and inflammation. Matern Child Nutr. 2018 Jul;14(3):e12585. doi: 10.1111/mcn.12585. Epub 2018 Jan 8. — View Citation
Asundep NN, Jolly PE, Carson AP, Turpin CA, Zhang K, Wilson NO, Stiles JK, Tameru B. Effect of Malaria and Geohelminth Infection on Birth Outcomes in Kumasi, Ghana. Int J Trop Dis Health. 2014;4(5):582-594. — View Citation
Bhutta ZA, Das JK, Rizvi A, Gaffey MF, Walker N, Horton S, Webb P, Lartey A, Black RE; Lancet Nutrition Interventions Review Group, the Maternal and Child Nutrition Study Group. Evidence-based interventions for improvement of maternal and child nutrition: — View Citation
Brooker S, Bethony J, Hotez PJ. Human hookworm infection in the 21st century. Adv Parasitol. 2004;58:197-288. Review. — View Citation
Kavle JA, Landry M. Addressing barriers to maternal nutrition in low- and middle-income countries: A review of the evidence and programme implications. Matern Child Nutr. 2018 Jan;14(1). doi: 10.1111/mcn.12508. Epub 2017 Aug 24. Review. — View Citation
Lassi ZS, Salam RA, Haider BA, Bhutta ZA. Folic acid supplementation during pregnancy for maternal health and pregnancy outcomes. Cochrane Database Syst Rev. 2013 Mar 28;(3):CD006896. doi: 10.1002/14651858.CD006896.pub2. Review. — View Citation
Prociv P, Luke RA. Evidence for larval hypobiosis in Australian strains of Ancylostoma duodenale. Trans R Soc Trop Med Hyg. 1995 Jul-Aug;89(4):379. — View Citation
Rasmussen KM, Stoltzfus RJ. New evidence that iron supplementation during pregnancy improves birth weight: new scientific questions. Am J Clin Nutr. 2003 Oct;78(4):673-4. — View Citation
Tuddenham S, Ghanem KG, Caulfield LE, Rovner AJ, Robinson C, Shivakoti R, Miller R, Burke A, Murphy C, Ravel J, Brotman RM. Associations between dietary micronutrient intake and molecular-Bacterial Vaginosis. Reprod Health. 2019 Oct 22;16(1):151. doi: 10.1186/s12978-019-0814-6. — View Citation
Verstraelen H, Delanghe J, Roelens K, Blot S, Claeys G, Temmerman M. Subclinical iron deficiency is a strong predictor of bacterial vaginosis in early pregnancy. BMC Infect Dis. 2005 Jul 6;5:55. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Adherence to iron and folic acid supplementation during pregnancy | Monthly disappearance rate of IFA tablets | Monthly during six months pregnancy | |
Primary | Adherence to iron and folic acid supplementation post-partum | Monthly disappearance rate of IFA tablets | Monthly during three months postpartum | |
Primary | Maternal anemia during pregnancy | Hemoglobin concentrations (g/dL) | Hemoglobin concentrations will be measured at 9 months pregnancy | |
Primary | Maternal anemia post-partum | Hemoglobin concentrations (g/dL) | Hemoglobin concentrations will be measured at six months postpartum | |
Primary | Early initiation | Prevalence of newborns put to the breast in the first hour after birth | At birth (six months after the enrollment) | |
Primary | Exclusive breastfeeding | Prevalence of infants exclusively breastfed using maternal reports and the deuterium dose-to-mother technique (in a subgroup) | Birth to six months postpartum | |
Primary | Dietary intake during six months pregnancy | Prevalence of women with adequate dietary intake during six months pregnancy | Assessed at 6 months and 9 months pregnancy | |
Primary | Dietary intake at six months post-partum | Prevalence of women with adequate dietary intake at six months post-partum | Assessed at six months postpartum | |
Secondary | Gestational weight gain | Weight gain at term (Kg) | Gestational weight gain will be measured in all pregnant women at six and nine months pregnancy | |
Secondary | Maternal genital infections | The presence of genital infections that are known to affect a healthy pregnancy, including but not limited to bacterial vaginosis, Chlamydia trachomatis, Neisseria gonorrhoeae, Trichomonas vaginalis, Listeria monocytogenes. | Maternal genital infections will be assessed at nine months pregnancy | |
Secondary | Birth weight | Birth weight (g) | Birth weight will be assessed in all newborns | |
Secondary | Infant weight | Infant weight (g) on a monthly basis | Weight of infants will be assessed monthly from birth until six months of age | |
Secondary | Infant length | Infant length (cm) on a monthly basis | Length of infants will be assessed monthly from birth until six months of age | |
Secondary | Infant anemia | Hemoglobin concentrations (g/dL) | Hemoglobin concentrations will be measured at six months of age | |
Secondary | Maternal parasitic infections | The presence of worm parasites and egg density in the stools. Three common parasites and their eggs will be investigated, i.e. Ascaris lumbricoides (round worm), Trichuris trichiura (whipworm) and Ancyclostoma duodenale or Necater americanus (hookworms). | Worm infections will be assessed in all women at 6 months pregnancy, 9 months pregnancy, and at two weeks- and 6 months post partum | |
Secondary | Infant parasitic infections | The prevalence of Giarida and Cryposporidium will be assessed in all infants | Infant parasitic infections will be assessed at 6 months of age. | |
Secondary | Maternal plasma ferritin | Iron status as indicated plasma ferritin (micro_g/L) is a test to evaluate iron stores | Plasma ferritin is assessed in a subgroup of women at 9 months pregnancy and at six months postpartum | |
Secondary | Infant plasma ferritin | Iron status as indicated plasma ferritin (micro_g/L) is a test to evaluate iron stores | Plasma ferritin is assessed in a subgroup of infants at six months of age | |
Secondary | Maternal soluble transferrin receptor | Soluble transferrin receptor (mg/L) is an indicator for iron deficiency especially in high inflammation settings | Plasma ferritin is assessed in a subgroup of women at 9 months pregnancy and at six months postpartum | |
Secondary | Infant soluble transferrin receptor | Soluble transferrin receptor (mg/L) is an indicator for iron deficiency especially in high inflammation settings | Soluble transferrin receptor is assessed in a subgroup of infants at six months of age | |
Secondary | Maternal serum concentrations in Vitamin A (retinol) | Retinol concentrations in serum is an indicator of vitamin A status | Serum concentrations in Vitamin A are assessed in a subgroup of women at 9 months pregnancy and at six months postpartum | |
Secondary | Infant serum concentrations in Vitamin A (retinol) | Retinol concentrations in serum is an indicator of vitamin A status | Serum concentrations in Vitamin A are assessed in a subgroup of infants at six months of age | |
Secondary | Maternal serum concentrations in vitamin B12 | Serum concentrations in vitamin B12 | Vitamin B12 concentrations will be assessed in a subgroup of women at 9 months pregnancy and at six months postpartum | |
Secondary | Infant serum concentrations in vitamin B12 | Serum concentrations in vitamin B12 | Vitamin B12 concentrations will be assessed in a subgroup of infants at six months of age |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
Completed |
NCT02948283 -
Metformin Hydrochloride and Ritonavir in Treating Patients With Relapsed or Refractory Multiple Myeloma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
Completed |
NCT03341338 -
Genes-in-Action - Hepcidin Regulation of Iron Supplementation
|
||
Completed |
NCT00060398 -
Epoetin Alfa With or Without Dexamethasone in Treating Fatigue and Anemia in Patients With Hormone-Refractory Prostate Cancer
|
Phase 3 | |
Recruiting |
NCT05384691 -
Efficacy of Luspatercept in ESA-naive LR-MDS Patients With or Without Ring Sideroblasts Who do Not Require Transfusions
|
Phase 2 | |
Not yet recruiting |
NCT06309641 -
Methemoglobinemia Following Intravenous Iron Treatment
|
||
Completed |
NCT02912494 -
A Phase III Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT02912533 -
A Long-term Study of JR-131 in Renal Anemia Patients With Chronic Kidney Disease (CKD)
|
Phase 3 | |
Completed |
NCT03822884 -
Pharmacokinetic/Pharmacodynamic Study of 3 Subcutaneous Single Dose Epoetin Alfa Formulations in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT02888171 -
Impact of Ferric Citrate vs Ferrous Sulfate on Iron Parameters and Hemoglobin in Individuals With CKD and Iron Deficiency
|
N/A | |
Completed |
NCT02930850 -
Spot-Check Noninvasive Hemoglobin (SpHb) Clinical Validation
|
N/A | |
Completed |
NCT02603250 -
Evaluation of Hemoglobin Measurement Tools for Child Anemia Screening in Rwanda
|
N/A | |
Completed |
NCT02384122 -
Efficacy of Octreotide on Blood and Iron Requirements in Patients With Anemia Due to Angiodysplasias
|
Phase 3 | |
Completed |
NCT02176759 -
Iron Absorption From Rice Fortified With Ferric Pyrophosphate
|
N/A | |
Withdrawn |
NCT01934842 -
A Study to Compare Analyte Levels in Blood Collected Using an Investigational Collection Device With a Commercial Predicate
|
N/A | |
Completed |
NCT02310113 -
Transfusion and Skeletal Muscle Tissue Oxygenation
|
N/A | |
Completed |
NCT01922479 -
Pilot Study of Ferric Carboxymaltose to Treat Iron Deficiency in Asians With Heart Failure
|
Phase 4 | |
Completed |
NCT01693029 -
Study to Compare Safety and Efficacy of HX575 Epoetin Alfa and US-licensed Epoetin Alfa
|
Phase 3 | |
Completed |
NCT01432717 -
Study of ACE-536 in Healthy Postmenopausal Women
|
Phase 1 | |
Completed |
NCT01458028 -
Age and Gender Effects on the Pharmacokinetics of BAY85-3934
|
Phase 1 |